The global blood typing market is projected to experience robust growth with a compound annual growth rate (CAGR) of 10.36% ...

Vaxxas, a clinical-stage biotechnology company, today announced it has secured a new patent from the United States patent office covering proprietary manufacturing technology for its novel vaccination ...

The global peptide microarray market share analysis is on a steady growth trajectory, projected to reach USD 903.8 million by 2025, with a compound annual growth rate (CAGR) of 3.8%. By 2035, the ...

today announced the publication of data supporting the effective use of its high-density microarray patch (HD-MAP) technology to deliver nucleic acid-based vaccines in collaboration with The ...

New data announced by Vaxxas supports the use of its high-density microarray patch (HD-MAP) technology to deliver DNA-based vaccines.

Clinical-stage biotechnology company Vaxxas has announced the publication of data supporting the potential use of its ...

PORTLAND, IL, UNITED STATES, March 11, 2025 /EINPresswire / -- The proteomics market is witnessing significant growth propelled by advancements in technology, such as mass spectrometry and protein ...

Integrity Marketing Group, LLC ("Integrity"), a leading distributor of life and health insurance, and provider of wealth management and retirement planning solutions, today announced it has partnered ...

The Global Fusion Biopsy Market Size is projected to grow at a CAGR of 8.9% from 2025 to 2032, according to a new report published by Verified Market Research ®. The report reveals that the market was ...

Today, Benzinga's options scanner identified 8 options transactions for Illumina. This is an unusual occurrence. The ...

The global DNA diagnostics market is on an impressive growth trajectory, with sales projected to reach USD 27,094.2 million in 2024, and further expanding to USD 57,420.1 million by 2034. This surge ...